POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)

UCB Pharma200 enrolled

Overview

Comparative study on clinical efficacy and safety of levocetirizine and desloratadine as measured by the subject's satisfaction/dissatisfaction after one week of treatment

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

DOUBLE

Enrollment

200

Conditions

Seasonal Allergic Rhinitis

Interventions

LevocetirizineDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical history of SAR known and treated since 2 years. * Positive skin prick test (wheal \> 3 mm larger than the diluent control) or RAST (≥3.5 IU/ml) to grass pollen (less than 1 year). * Minimum mean T5SS of 8 during the baseline period. Exclusion Criteria: * Have an associated asthma requiring a daily treatment other than β2 short acting agonist prn * Have atopic dermatitis or urticaria requiring antihistamine treatment or the administration of oral or topical corticosteroids and any other disease requiring the administration of oral or topical corticosteroids

Outcomes

Primary Outcomes

Subjects' satisfaction / dissatisfaction after the first week of treatment.

Secondary Outcomes

allergic rhinitis symptoms scores over the first week of treatment , subject's satisfaction / dissatisfaction of their choice of treatment after the first week of treatment, time to first feeling of (sufficient) symptom improvement during the first we

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.